Skip to content
healthcare.dev

Lacosamide

NDC 71921-222, Lacosamide, tablet, from Florida Pharmaceutical Products, LLC.

Product NDC
71921-222
Status
Listed
Labeler
Florida Pharmaceutical Products, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208308
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71921-222 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE150 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
71921-222-067192102220660 TABLET in 1 BOTTLE (71921-222-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3680c0ff-7f5c-4572-b1eb-4fea96b7fbe2

Use it

Look up 71921-222 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71921-222 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71921-222. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.